Vendor, Watertown, MA
Pathcision Medicine, Inc.
UEI CK6QRF2GLBT1, CAGE 9BD69
1 award and $299,981 obligated between August 5, 2025 and July 20, 2026, 100% under full and open competition, against 55.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $299,981 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91025C00018Definitive Contract, August 5, 2025, Full and Open Competition After Exclusion of Sources, 55 offers | NIH NCINational Institutes of Health | SBIR Concept Award for a Novel Delivery Approach to Transform Metastatic Pancreatic Cancer Treatment and PreventionNAICS 541714, PSC AN12 | $299,981 |
- Places of performance
- Massachusetts
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 2 across 1 awards